New!! FGFR Companion Diagnostic assay for Urothelial Cancer

Posted on May 07 2019 by nmorton

Molecular Pathology Laboratory Network Inc. now offers evaluation of FGFR alterations for treatment of urothelial carcinoma with BALVERSA™ (erdafitinib)
On April 12, 2019 FDA approved Janssen’s Balversa™ (erdafitinib)…
Read more

MPLN Presents NGS Workshop at 13th International Conference on Pathology and Molecular Diagnostics

Posted on June 23 2017 by J Seabrook

San Diego June 27th is host to Dr. Tandon's workshop on contemporary genomic studies in hematologic pathology: Utility of next generation sequencing in clinical evaluation of myeloid and lymphoid malignancies.

Next generation sequencing…
Read more


MPLN and Geneuity Twitter News Feed

Posted on June 22 2017 by J Seabrook

You can view MPLN's Twitter Feed by clicking here @molpathnet

Molecular Pathology Laboratory Network, custom services for #oncologists #pathologists;
experience in #flowcytometry…
Read more

MPLN expands oncology offering with Next Generation Sequencing based mutation panels for evaluation

Posted on May 18 2017 by J Seabrook

Myeloproliferative neoplasms (MPNs) are characterized by excess accumulation of one or more myeloid cell lineages and a tendency to transform to acute leukemia.  Clinical data and practice guidelines have evolved at a rapid pace for this heterogeneous…
Read more


MPLN offers VENTANA SP263 PDL-1 by IHC

Posted on May 02 2017 by J Seabrook

MPLN offers SP263 immunohistochemical testing for the assessment of the PD-L1 protein in formalin-fixed, paraffin-embedded tissue. PD-L1 expression level utilizing this clone has been associated with response to durvalumab (IMFINZI, AstraZeneca UK…
Read more

1 2 3 4 5 6 7 8